Cytokines as Prognostic Biomarkers in Pulmonary Arterial Hypertension.
Athénaïs BouclyLy TuChristophe GuignabertChristopher RhodesPascal De GrooteGrégoire PrévotEmmanuel BergotArnaud BourdinAntoine BeurnierAnne RocheMitja JevnikarXavier JaïsI David MontaniMartin R WilkinsMarc HumbertOlivier SitbonLaurent SavalePublished in: The European respiratory journal (2022)
The monitoring of ß-NGF, CXCL9 and TRAIL levels in serum should be considered in the management and treatment of patients with PAH to objectively guide therapeutic options.